Dextromethorphan/Morphine

右美沙芬/吗啡

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDextromethorphan/Morphine
Drug Alias NameMorphine/dextromethorphan吗啡/右美沙芬Morphine+dextromethorphanDextromethorphan+morphineMorphiDex +[6] 
ClassificationSmall molecules
Mechanisms of ActionOpioid receptors agonistsGlutamate [NMDA] receptor antagonists
TargetsOpioid receptorsGlutamate [NMDA] receptor
Therapy Area/IndicationsCancer Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Morphine sulfateDextromethorphan Hydrobromide
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEndo International Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndo International Plc
Active IndicationsN/A
Inactive IndicationsCancer Pain

Other Information

ATC CodeN/A
Related LinksN/A